{
    "SPADE_N_15067": {
        "Sequence Information": {
            "Peptide Name": "Siamycin II",
            "Sequence": "CLGIGSCNDFAGCGYAIVCFW",
            "Sequence Length": 21,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antiviral",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Streptomyces sp. AA3891 ATCC 55286",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Siamycins I and II, new anti-HIV peptides: I. Fermentation, isolation, biological activity and initial characterization.",
                    "Pubmed ID": "7797448",
                    "Reference": "J Antibiot (Tokyo). 1995;48:433-434",
                    "Author": "Tsunakawa M, Hu SL, Hoshino Y, Detlefson DJ, Hill SE, Furumai T, White RJ, Nishio M, Kawano K, Yamamoto S, et al.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/7797448"
                }
            ],
            "Mass": 2199.55,
            "PI": 4.05,
            "Net Charge": -1,
            "Hydrophobicity": 1.17,
            "Frequent Amino Acids": "CGA",
            "Absent Amino Acids": "EHKMOPQRTU",
            "Basic Residues": 0,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 12,
            "Polar Residues": 9,
            "Positive Residues": 0,
            "Negative Residues": 1,
            "SPADE ID": "SPADE_N_15067",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_11376",
                    "Similarity": 1.0,
                    "Sequence": "CLGIGSCNDFAGCGYAIVCFW"
                },
                {
                    "SPADE_ID": "SPADE_N_05603",
                    "Similarity": 0.9523809523809523,
                    "Sequence": "CLGVGSCNDFAGCGYAIVCFW"
                },
                {
                    "SPADE_ID": "SPADE_N_14059",
                    "Similarity": 0.9523809523809523,
                    "Sequence": "CLGIGSCDDFAGCGYAIVCFW"
                }
            ],
            "Hemolytic Activity": "CEM-SS cells:50% Cytotoxicity=>500 µg/ml",
            "Target Organism": "Staphylococcus aureus FDA 209P JC-1(MIC=3.1µg/ml),Staphylococcus aureus Smith(MIC=6.3µg/ml),Staphylococcus aureus MR(MIC=3.1µg/ml),Micrococcus luteus ATCC 9341(MIC=1.6µg/ml),Bacillus subtilis ATCC 6633(MIC=1.6µg/ml),Escherichia coli(MIC=>100µg/ml),Escherichia coli K-12(MIC=>100µg/ml),Escherichia coli NIHJ JC-2(MIC=>100µg/ml),Klebsiella pneumoniae ATCC 10031(MIC=>100µg/ml),Citrobacter freundii(MIC=>100µg/ml),Salmonella enterica subsp. enterica serovar Typhi(MIC=>100µg/ml),Pseudomonas aeruginosa(MIC=>100µg/ml),HIV-1(IC50=9µg/ml),HSV-1(IC50=27µg/ml)"
        }
    }
}